Understanding and minimizing late thrombosis of drug-eluting stents

Mark G. Rabbat, MD
Department of Internal Medicine, Cleveland Clinic

Anthony A. Bavry, MD, MPH
Department of Cardiovascular Medicine, Cleveland Clinic

Deepak L. Bhatt, MD
Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine; Associate Director, Cleveland Clinic Cardiovascular Coordinating Center; Staff, Cardiac, Peripheral, and Carotid Intervention, Department of Cardiovascular Medicine, Cleveland Clinic

Stephen G. Ellis, MD
Professor of Medicine, Cleveland Clinic Lerner College of Medicine; Head, Section of Invasive Cardiology, Department of Cardiovascular Medicine, Cleveland Clinic

Address: Stephen G. Ellis, MD, Department of Cardiovascular Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Dr. Bavry has received honoraria from Genesis.

Dr. Bhatt has served as a consultant to AstraZeneca, Bristol-Myers Squibb, Centocor, Daiichi-Sankyo, Eisai, Eli Lilly, GlaxoSmithKline, Millennium, Paringenix, PDL, Sanofi-Aventis, Schering-Plough, and The Medicines Company.

Dr. Ellis has served as a consultant to Cordis, Boston Scientific, and Abbott, and receives research support from Cordis and Medtronic.

Mark G. Rabbat, MD
Department of Internal Medicine, Cleveland Clinic

Anthony A. Bavry, MD, MPH
Department of Cardiovascular Medicine, Cleveland Clinic

Deepak L. Bhatt, MD
Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine; Associate Director, Cleveland Clinic Cardiovascular Coordinating Center; Staff, Cardiac, Peripheral, and Carotid Intervention, Department of Cardiovascular Medicine, Cleveland Clinic

Stephen G. Ellis, MD
Professor of Medicine, Cleveland Clinic Lerner College of Medicine; Head, Section of Invasive Cardiology, Department of Cardiovascular Medicine, Cleveland Clinic

Address: Stephen G. Ellis, MD, Department of Cardiovascular Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Dr. Bavry has received honoraria from Genesis.

Dr. Bhatt has served as a consultant to AstraZeneca, Bristol-Myers Squibb, Centocor, Daiichi-Sankyo, Eisai, Eli Lilly, GlaxoSmithKline, Millennium, Paringenix, PDL, Sanofi-Aventis, Schering-Plough, and The Medicines Company.

Dr. Ellis has served as a consultant to Cordis, Boston Scientific, and Abbott, and receives research support from Cordis and Medtronic.

Mark G. Rabbat, MD
Department of Internal Medicine, Cleveland Clinic

Anthony A. Bavry, MD, MPH
Department of Cardiovascular Medicine, Cleveland Clinic

Deepak L. Bhatt, MD
Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine; Associate Director, Cleveland Clinic Cardiovascular Coordinating Center; Staff, Cardiac, Peripheral, and Carotid Intervention, Department of Cardiovascular Medicine, Cleveland Clinic

Stephen G. Ellis, MD
Professor of Medicine, Cleveland Clinic Lerner College of Medicine; Head, Section of Invasive Cardiology, Department of Cardiovascular Medicine, Cleveland Clinic

Address: Stephen G. Ellis, MD, Department of Cardiovascular Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Dr. Bavry has received honoraria from Genesis.

Dr. Bhatt has served as a consultant to AstraZeneca, Bristol-Myers Squibb, Centocor, Daiichi-Sankyo, Eisai, Eli Lilly, GlaxoSmithKline, Millennium, Paringenix, PDL, Sanofi-Aventis, Schering-Plough, and The Medicines Company.

Dr. Ellis has served as a consultant to Cordis, Boston Scientific, and Abbott, and receives research support from Cordis and Medtronic.